TRAVERE THERAPEUTICS INC holding history
As of Nov. 6, 2026 (UTC)
| Sept. 30, 2025 | 1,599,668 | $38,232,065 | 0.50% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 28, 2025 |
| Dec. 31, 2025 | 1,721,623 | $65,783,215 | 0.86% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 5, 2026 |
| March 31, 2026 | 1,798,466 | $53,432,425 | 0.73% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | April 28, 2026 |
| June 30, 2026 | 1,875,304 | $106,536,020 | 1.14% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 29, 2026 |
4 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.